Table 2.
Resistance profile and gene associated.
| Beta-lactams | Fluorochinolone | Aminoglycoside | Colistine | Fosfomycin | Sulfonamide | Beta-Lactamase | Fluorochinolone | Aminoglycoside | Fosfomycin | Sulfonamide | phenicoles | Macrolides Eritromycin Tetracicline | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | MLST | wzi | K-locus | O-locus | CZA | AMC | TZP | FEP | CAZ | C/T | MEM | IMI | AZT | MEV | FDC | CIP | TOB | AK | GM | CS | FOS | SXT | SHV-28 | SHV-45 | SHV-55 | SHV-100 | SHV-106 | SHV-187 | SHV-205 | SHV-212 | KPC-3 | KPC-28 | KPC-31 | KPC-34 | KPC-50 | OXA-1 | OXA-9 | TEM-181 | CTX-M-15 | QnrS1 | QnrB17 | APH(3')-Ia | APH(3'')-Ib | APH(3'')-Ib10 | APH(6)-Id | AAC(3)-IIe | AAC(6')-Ib-cr6 | AAC(6')-Ib10 | aadA2 | ANT(2'')-Ia | ANT(3'')-IIa | ArmA | FosA6 | sul1 | sul2 | dfrA12 | dfrA14 | qacEdelta1 | catB3 | catImphA mphE msrE tet(A) | |
| 1CT | 2020 | ST101 | 137 | K17 | O1/O2v1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 10 1 1 0 | ||||||||||||||||||
| 2CT | 2020 | ST101 | 137 | K17 | O1/O2v1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 10 1 1 0 | ||||||||||||||||||
| 3CT | 2020 | ST101 | 137 | K17 | O1/O2v1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 10 1 1 0 | ||||||||||||||||||
| 4CT | 2021 | ST101 | 137 | K17 | O1/O2v1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 10 1 1 0 | ||||||||||||||||||
| 5CT | 2021 | ST101 | 137 | K17 | O1/O2v1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 00 0 0 0 | ||||||||||||||||||
| 1CZ | 2020 | ST307 | 173 | K102 | O1/O2v2 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 00 0 0 0 | ||||||||||||||||||
| 2CZ | 2020 | ST512 | 154 | K107 | O1/O2v2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 11 0 0 0 | ||||||||||||||||||
| 3CZ | 2020 | ST512 | 154 | K107 | O1/O2v2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 11 0 0 0 | ||||||||||||||||||
| 4CZ | 2020 | ST307 | 173 | K102 | O1/O2v2 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 01 0 0 0 | ||||||||||||||||||
| 5CZ | 2020 | ST512 | 154 | K107 | O1/O2v2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 00 0 0 1 | ||||||||||||||||||
| 6CZ | 2020 | ST512 | 154 | K107 | O1/O2v2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 11 0 0 0 | ||||||||||||||||||
| 7CZ | 2020 | ST512 | 154 | K107 | O1/O2v2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 11 0 0 0 | ||||||||||||||||||
| 8CZ | 2020 | ST512 | 154 | K107 | O1/O2v2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 11 0 0 0 | ||||||||||||||||||
| 9CZ | 2020 | ST512 | 154 | K107 | O1/O2v2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 11 0 0 0 | ||||||||||||||||||
| 10CZ | 2020 | ST101 | 137 | K17 | O1/O2v1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 01 1 1 0 | ||||||||||||||||||
| 12CZ | 2021 | ST307 | 173 | K102 | O1/O2v2 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 01 0 0 0 | ||||||||||||||||||
Antibiotic tested: CZA, ceftazidime/avibactam; AMC, amoxicillin/clavulanate; TZP, piperacillin/tazobactam; FEP, cefepime; CAZ, ceftazidime; C/T, ceftazolane/tazobactam; MEM- meropenem; IMI, imipenem; AZT, aztreonam; MEV- meropenem/vaporbactam ; FDC, cefiderocol; CIP, ciprofloxacin; TOB, tobramycin; AK, amikacin; CN, gentamycin; CS, colistin; FOS, fosfomycin; SXT,trimethoprim/sulfamethoxazole.
The antibiotic resitance or gene presence were reported as a coloured square:
Beta-lactams,
Fluorochinolones,
Aminoglycoside,
Colistine,
Fosfomycine,
Sulfonamides,
Miscellaneus.